Dataset summary
TF Name: | ERF | Species: | Homo sapiens |
Cell-type/Tissue: | VCaP (prostate carcinoma) | Condition/Source: | |
JASPAR ID: | MA0760.1 | Collections: | Permissive Robust |
References: | GEO GSE98809 GSM2612450 GSM2612451 GTRD EXP038639 PUBMED 28614298 |
Statistical details
Model | Peak caller | Model ID | Enrichment Zone | TFBSs | Score threshold | Centrality p-value (log10) |
---|---|---|---|---|---|---|
DAMO | MACS | MA0760.1 | 87.5 | 10409 | 89.9 | -5.07507520324318 |
14 datasets found for the same TF (ERF) in other cell-types/tissues
TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
---|---|---|---|---|---|---|
ERF | embryonic fibroblasts | starved | Permissive | Mus musculus | GSE42936 ... | MA0760.1 |
ERF | embryonic fibroblasts | exponential | Permissive | Mus musculus | GSE42936 ... | MA0760.1 |
ERF | embryonic stem cells | Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: 4-hydroxy-tamoxifen for at least 7days Background: cell line RAS lox/lox | Permissive | Mus musculus | GSE99476 ... | MA0760.1 |
ERF | embryonic stem cells | Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: 4-hydroxy-tamoxifen for at least 7days Background: cell line RAS lox/lox | Permissive Robust | Mus musculus | GSE99476 ... | MA0760.1 |
ERF | embryonic stem cells | Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Background: cell line RAS lox/lox | Permissive | Mus musculus | GSE99476 ... | MA0760.1 |
ERF | embryonic stem cells | Treatment: no Genotype: ERF wildtype, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Background: cell line RAS lox/lox | Permissive | Mus musculus | GSE99476 ... | MA0760.1 |
ERF | embryonic stem cells | Genotype: ERF knockout, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: no for at least 7days Background: cell line RAS lox/lox | Permissive | Mus musculus | GSE99476 ... | MA0760.1 |
ERF | embryonic stem cells | Genotype: ERF knockout, (H-Ras-/-;N-Ras-/-;K-Raslox/lox;RERTert/ert) Treatment: no for at least 7days Background: cell line RAS lox/lox | Permissive | Mus musculus | GSE99476 ... | MA0760.1 |
ERF | prostate organoids | Treatment: vehicle; | Permissive Robust | Mus musculus | GSE98808 ... | MA0760.1 |
ERF | prostate organoids | Treatment: vehicle; | Permissive | Mus musculus | GSE98808 ... | MA0760.1 |
ERF | prostate organoids | Treatment: 100ng/mL doxycycline; | Permissive | Mus musculus | GSE98808 ... | MA0760.1 |
ERF | prostate organoids | Treatment: 100ng/mL doxycycline; | Permissive | Mus musculus | GSE98808 ... | MA0760.1 |
ERF | HepG2 (hepatoblastoma) | Permissive | Homo sapiens | ENCSR159DQO | MA0760.1 | |
ERF | VCaP (prostate carcinoma) | Permissive Robust | Homo sapiens | GSE98809 ... | MA0760.1 |